Technical Analysis for ACRV - Acrivon Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 14.22 | -1.46% | -0.21 |
ACRV closed down 0.69 percent on Monday, January 30, 2023, on 8 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | N/A | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Shooting Star Candlestick | Bearish | -1.46% | |
| Doji - Bearish? | Reversal | -1.46% | |
| Outside Day | Range Expansion | -1.46% | |
| Wide Bands | Range Expansion | -1.46% | |
| NR7 | Range Contraction | -2.13% | |
| Narrow Range Bar | Range Contraction | -2.13% | |
| Inside Day | Range Contraction | -2.13% | |
| Wide Bands | Range Expansion | -2.13% | |
| Gapped Up | Strength | -2.13% | |
| Hammer Candlestick | Bullish | -0.49% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Up 3% | about 4 hours ago |
| Down 1% | about 4 hours ago |
| Up 2% | about 4 hours ago |
| Up 1% | about 4 hours ago |
| Fell Below Previous Day's Low | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops precision oncology medicines. The company's lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1/2 for use in the treatment of platinum-resistant ovarian cancer; endometrial and bladder cancer; and SCCs, including SCCHN, cervical, and anal cancer. It is also developing two preclinical drug programs used to predict tumor sensitivity based on custom OncoSignature tests. The company was incorporated in 2018 and is based in Watertown, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Oncology Tumor Ovarian Cancer Bladder Cancer Gynaecological Cancer Anal Cancer
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Oncology Tumor Ovarian Cancer Bladder Cancer Gynaecological Cancer Anal Cancer
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 20.7031 |
| 52 Week Low | 10.9006 |
| Average Volume | 30,817 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 12.73 |
| 20-Day Moving Average | 12.91 |
| 10-Day Moving Average | 14.01 |
| Average True Range | 0.84 |
| RSI | 62.69 |
| ADX | 26.06 |
| +DI | 26.68 |
| -DI | 14.87 |
| Chandelier Exit (Long, 3 ATRs) | 12.86 |
| Chandelier Exit (Short, 3 ATRs) | 13.88 |
| Upper Bollinger Bands | 15.37 |
| Lower Bollinger Band | 10.46 |
| Percent B (%b) | 0.81 |
| BandWidth | 38.05 |
| MACD Line | 0.59 |
| MACD Signal Line | 0.34 |
| MACD Histogram | 0.2474 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 15.60 | ||||
| Resistance 3 (R3) | 15.66 | 15.33 | 15.41 | ||
| Resistance 2 (R2) | 15.33 | 15.03 | 15.30 | 15.34 | |
| Resistance 1 (R1) | 14.88 | 14.85 | 15.11 | 14.82 | 15.27 |
| Pivot Point | 14.55 | 14.55 | 14.66 | 14.52 | 14.55 |
| Support 1 (S1) | 14.10 | 14.25 | 14.33 | 14.04 | 13.59 |
| Support 2 (S2) | 13.77 | 14.07 | 13.74 | 13.52 | |
| Support 3 (S3) | 13.32 | 13.77 | 13.46 | ||
| Support 4 (S4) | 13.26 |
